Compound ID | 772

EP-13420

Class: Macrolide (ketolide)

Spectrum of activity: Gram-negative
Details of activity: Protein synthesis inhibitor; effective against repiratory tract infections and H. influenzae. It demonstrates good pharmokinetics in the mouse and dog animal model with half life of 10.8hrs and lung tissue to plasma ratio over 4 times greater than telithromycin. Was in development for CAP and respiratory tract infections. Enanta Pharmaceuticals no longer has this in pipeline on their website.
Description: Scorneaux B, Arya A, Polemeropoulos, et al. A novel ketolide highly active against resistant pathogens and having exceptional pharmokinetic properties in the dog. 43rd-ICAAC 2003;243
Institute where first reported: Enanta Pharmaceuticals, USA
Year first mentioned: 2003
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 841
Iso. SMILES: CC[C@@H]1[C@@]([C@H]2[C@H](C(=NC(=O)C)[C@@H](C[C@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(OC/C(=N/OCC4=CN=C(C=C4)N5C=CC=N5)/CO2)C)C)C)(C)O
InChI Key: WLGSYOKBEDVHQB-ZIJNRMRWSA-N
Can. SMILES: CC[C@@H]1[C@](C)([C@H]2[C@@H](C)C(=NC(=O)C)[C@H](C)C[C@](C)([C@@H]([C@@H](C)C(=O)[C@@H](C)C(=O)O1)O[C@H]3[C@@H]([C@H](C[C@@H](C)O3)N(C)C)O)OC/C(=N/OCC4=CC=C(N=C4)N5C=CC=N5)/CO2)O
InChI: InChI=1S/C43H64N6O11/c1-12-33-43(9,54)39-26(4)35(46-29(7)50)24(2)19-42(8,56-23-31(22-55-39)47-57-21-30-14-15-34(44-20-30)49-17-13-16-45-49)38(27(5)36(51)28(6)40(53)59-33)60-41-37(52)32(48(10)11)18-25(3)58-41/h13-17,20,24-28,32-33,37-39,41,52,54H,12,18-19,21-23H2,1-11H3/b46-35?,47-31+/t24-,25-,26+,27+,28-,32+,33-,37-,38-,39-,41+,42-,43-/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9875927
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.